MX2020008198A - Composicion del conjugado proteina-polisacarido multivalente neumococica. - Google Patents

Composicion del conjugado proteina-polisacarido multivalente neumococica.

Info

Publication number
MX2020008198A
MX2020008198A MX2020008198A MX2020008198A MX2020008198A MX 2020008198 A MX2020008198 A MX 2020008198A MX 2020008198 A MX2020008198 A MX 2020008198A MX 2020008198 A MX2020008198 A MX 2020008198A MX 2020008198 A MX2020008198 A MX 2020008198A
Authority
MX
Mexico
Prior art keywords
sub
multivalent pneumococcal
serotypes
conjugated
protein conjugate
Prior art date
Application number
MX2020008198A
Other languages
English (en)
Inventor
Hun Kim
Philippe Talaga
Kyungjun An
Dongsoo Ham
Jinhwan Shin
Robert Hopfer
Richard D Kensinger
Moe Kyaw
Sunghyun Kim
Original Assignee
Sanofi Pasteur Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Pasteur Inc filed Critical Sanofi Pasteur Inc
Publication of MX2020008198A publication Critical patent/MX2020008198A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/34—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Corynebacterium (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/46—Streptococcus ; Enterococcus; Lactococcus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Se proporcionan composiciones conjugadas multivalentes neumocócicas con portador mixto, que comprenden 21 conjugados de proteína-polisacárido capsular neumocócicos diferentes, donde cada uno de los conjugados incluye un polisacárido capsular de un serotipo diferente de Streptococcus pneumoniae conjugado con toxoide tetánico (TT) o CRM197, donde los serotipos de Streptococcus pneumoniae se seleccionan entre 1, 3, 4, 5, 6A, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 18C, 19A, 19F, 22F, 23F y 33F, donde los polisacáridos capsulares de dos de los serotipos de 1, 3, y 5 y uno o ambos de los dos serotipos 15B y 22F están conjugados con TT y los polisacáridos capsulares restantes están conjugados con CRM197. También se proporcionan métodos para producir las composiciones conjugadas multivalentes neumocócicas con portador mixto y métodos de uso de estas para la profilaxis frente a una infección o enfermedad por Streptococcus pneumoniae en un sujeto.
MX2020008198A 2018-02-05 2019-02-04 Composicion del conjugado proteina-polisacarido multivalente neumococica. MX2020008198A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862626509P 2018-02-05 2018-02-05
KR20180045246 2018-04-18
PCT/US2019/016511 WO2019152925A1 (en) 2018-02-05 2019-02-04 Multivalent pneumococcal polysaccharide-protein conjugate composition

Publications (1)

Publication Number Publication Date
MX2020008198A true MX2020008198A (es) 2020-09-22

Family

ID=67478943

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020008198A MX2020008198A (es) 2018-02-05 2019-02-04 Composicion del conjugado proteina-polisacarido multivalente neumococica.

Country Status (16)

Country Link
US (2) US11123417B2 (es)
EP (1) EP3749357A4 (es)
JP (4) JP6950099B2 (es)
KR (2) KR20230008923A (es)
CN (1) CN111757753A (es)
AR (1) AR127517A2 (es)
AU (1) AU2019215216A1 (es)
BR (1) BR112020015696A2 (es)
CA (1) CA3089007A1 (es)
IL (2) IL276230B2 (es)
MX (1) MX2020008198A (es)
PH (1) PH12020551149A1 (es)
SG (1) SG11202006388SA (es)
TW (1) TWI826420B (es)
WO (1) WO2019152925A1 (es)
ZA (1) ZA202202600B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11160855B2 (en) * 2014-01-21 2021-11-02 Pfizer Inc. Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
CA3031797A1 (en) 2016-08-05 2018-02-08 Sanofi Pasteur, Inc. Multivalent pneumococcal polysaccharide-protein conjugate composition
SG11201900794PA (en) 2016-08-05 2019-02-27 Sanofi Pasteur Inc Multivalent pneumococcal polysaccharide-protein conjugate composition
US11951165B2 (en) 2016-12-30 2024-04-09 Vaxcyte, Inc. Conjugated vaccine carrier proteins
MA47223A (fr) 2016-12-30 2019-11-06 Sutrovax Inc Conjugués polypeptide-antigène avec des acides aminés non naturels
US10729763B2 (en) 2017-06-10 2020-08-04 Inventprise, Llc Mixtures of polysaccharide-protein pegylated compounds
SG11202005255PA (en) 2017-12-06 2020-07-29 Merck Sharp & Dohme Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof
AU2019215212A1 (en) 2018-02-05 2020-07-23 Sk Bioscience Co., Ltd. Multivalent pneumococcal polysaccharide-protein conjugate composition
AU2019215216A1 (en) * 2018-02-05 2020-07-23 Sk Bioscience Co., Ltd. Multivalent pneumococcal polysaccharide-protein conjugate composition
US11951162B2 (en) * 2018-04-18 2024-04-09 Sk Bioscience Co., Ltd. Streptococcus pneumoniae capsular polysaccharides and immunogenic conjugate thereof
TWI788610B (zh) 2018-12-19 2023-01-01 美商默沙東有限責任公司 包含肺炎鏈球菌多醣-蛋白質結合物之組合物及其使用方法
CA3148824A1 (en) 2019-07-31 2021-02-04 Sanofi Pasteur Inc. Multivalent pneumococcal polysaccharide-protein conjugate compositions and methods of using the same
US20240181028A1 (en) 2022-11-22 2024-06-06 Pfizer Inc. Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof

Family Cites Families (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ239643A (en) 1990-09-17 1996-05-28 North American Vaccine Inc Vaccine containing bacterial polysaccharide protein conjugate and adjuvant (c-nd-che-a-co-b-r) with a long chain alkyl group.
US5153312A (en) 1990-09-28 1992-10-06 American Cyanamid Company Oligosaccharide conjugate vaccines
US5866132A (en) 1995-06-07 1999-02-02 Alberta Research Council Immunogenic oligosaccharide compositions
US5695768A (en) 1995-06-07 1997-12-09 Alberta Research Council Immunostimulating activity of Streptococcus pneumoniae serotype 8 oligosaccharides
NZ309713A (en) 1995-06-07 1999-11-29 Alberta Res Council Oligosaccharides of S pneumoniae serotype 8 and their use in a vaccine
CA2153733A1 (en) 1995-07-12 1997-01-13 Andrew J. Malcolm Immunogenic oligosaccharide compositions
CA2153730A1 (en) 1995-07-12 1997-01-13 Andrew J. Malcolm Immunostimulating activity of streptococcus pneumoniae serotype 8 oligosaccharides
FR2763244B1 (fr) * 1997-05-14 2003-08-01 Pasteur Merieux Serums Vacc Composition vaccinale multivalente a porteur mixte
EP1880735A3 (en) 1999-03-19 2008-03-12 GlaxoSmithKline Biologicals S.A. Vaccine
FR2806304B1 (fr) * 2000-03-17 2002-05-10 Aventis Pasteur Conjugues polysaccharidiques du pneumocoque a usage vaccinal contre le tetanos et la diphterie
GB0108364D0 (en) 2001-04-03 2001-05-23 Glaxosmithkline Biolog Sa Vaccine composition
CA2783274C (en) 2000-06-29 2018-08-07 Glaxosmithkline Biologicals S.A. Multivalent vaccine composition with reduced dose of haemophilus influenza type b
AU2007200116A1 (en) 2001-04-03 2007-02-01 Glaxosmithkline Biologicals S.A. Vaccine composition
GB0130215D0 (en) 2001-12-18 2002-02-06 Glaxosmithkline Biolog Sa Vaccine
TWI341210B (en) 2002-04-01 2011-05-01 Glaxosmithkline Biolog Sa Vaccine kit
TWI346555B (en) 2002-04-01 2011-08-11 Glaxosmithkline Biolog Sa Vaccine composition
CA2518669C (en) 2003-03-13 2014-07-29 Glaxosmithkline Biologicals S.A. Purification process
US7320874B2 (en) 2003-07-08 2008-01-22 Aventis Pasteur Sa Assaying the teichoic acids of gram+ bacteria
GB0421083D0 (en) 2004-09-22 2004-10-27 Glaxosmithkline Biolog Sa Purification process
ME01334B (me) 2005-04-08 2013-12-20 Wyeth Llc Polivalentni pripravak konjugata pneumokoknog polisaharida s proteinom
US7955605B2 (en) 2005-04-08 2011-06-07 Wyeth Llc Multivalent pneumococcal polysaccharide-protein conjugate composition
US7709001B2 (en) * 2005-04-08 2010-05-04 Wyeth Llc Multivalent pneumococcal polysaccharide-protein conjugate composition
AR058592A1 (es) 2005-12-22 2008-02-13 Glaxosmithkline Biolog Sa Vacuna
US8808707B1 (en) * 2006-05-08 2014-08-19 Wyeth Llc Pneumococcal dosing regimen
CN101883583B (zh) 2007-06-26 2017-05-17 葛兰素史密丝克莱恩生物有限公司 含有肺炎链球菌荚膜多糖缀合物的疫苗
RU2536248C2 (ru) 2009-04-30 2014-12-20 Коули Фармасьютикал Груп, Инк. Пневмококковая вакцина и ее применения
TW201136603A (en) 2010-02-09 2011-11-01 Merck Sharp & Amp Dohme Corp 15-valent pneumococcal polysaccharide-protein conjugate vaccine composition
CN101785857B (zh) 2010-03-05 2012-09-26 成都安特金生物技术有限公司 一种新的肺炎球菌结合疫苗及其制备方法
GB201003920D0 (en) 2010-03-09 2010-04-21 Glaxosmithkline Biolog Sa Method of treatment
KR101609032B1 (ko) 2010-06-04 2016-04-04 와이어쓰 엘엘씨 스트렙토코커스 뉴모니아 백신 제제
CN102068690A (zh) 2010-12-31 2011-05-25 北京民海生物科技有限公司 多价肺炎球菌荚膜多糖结合疫苗及其制备方法
KR102057217B1 (ko) 2012-06-20 2020-01-22 에스케이바이오사이언스 주식회사 다가 폐렴구균 다당류-단백질 접합체 조성물
RU2724840C2 (ru) 2012-08-16 2020-06-25 Пфайзер Инк. Способы гликоконъюгирования и композиции
CN103623401A (zh) * 2012-08-23 2014-03-12 北京科兴中维生物技术有限公司 多价肺炎球菌荚膜多糖-蛋白质共轭组合物及其制备方法
CN103656632B (zh) 2012-09-24 2016-01-13 北京科兴中维生物技术有限公司 多价肺炎球菌荚膜多糖组合物、其制备方法及应用
CN103656631B (zh) 2012-09-24 2015-08-19 北京科兴中维生物技术有限公司 多价肺炎球菌荚膜多糖-蛋白缀合物组合物及其制备方法
KR20140075196A (ko) 2012-12-11 2014-06-19 에스케이케미칼주식회사 다가 폐렴구균 다당류-단백질 접합체 조성물
KR20140075201A (ko) 2012-12-11 2014-06-19 에스케이케미칼주식회사 다가 폐렴구균 다당류-단백질 접합체 조성물
ITMI20130142A1 (it) 2013-01-31 2014-08-01 Biosynth Srl Vaccini glicoconiugati comprendenti unita' di base di un costrutto molecolare esprimente epitopi multipli incorporati
WO2015110940A2 (en) 2014-01-21 2015-07-30 Pfizer Inc. Streptococcus pneumoniae capsular polysaccharides and conjugates thereof
SI3583947T1 (sl) 2014-01-21 2024-01-31 Pfizer Inc. Kapsularni polisaharidi streptococcus pneumoniae in njihovi konjugati
AU2015208821B2 (en) 2014-01-21 2017-11-02 Pfizer Inc. Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
CN104069504B (zh) 2014-05-11 2019-09-24 江苏康泰生物医学技术有限公司 一种增强多糖蛋白结合物免疫原性的方法
CN107029225B (zh) 2014-07-25 2020-08-11 武汉博沃生物科技有限公司 一种缀合疫苗及其制备方法
PL3244917T3 (pl) 2015-01-15 2023-07-17 Pfizer Inc. Kompozycje immunogenne do zastosowania w szczepionkach przeciwko pneumokokom
SI3313436T1 (sl) 2015-06-23 2021-09-30 Biological E Limited Multivalentno konjugirano pnevmokokno cepivo
GB201518684D0 (en) 2015-10-21 2015-12-02 Glaxosmithkline Biolog Sa Vaccine
WO2017085586A1 (en) * 2015-11-20 2017-05-26 Pfizer Inc. Immunogenic compositions for use in pneumococcal vaccines
EP3436061A4 (en) 2016-03-31 2019-12-04 Liffey Biotech Limited Saccharide-polypeptide-conjugate compositions and methods of use thereof
CN106140046B (zh) 2016-07-06 2019-02-22 江南大学 阵列式感应电场流体反应系统及其应用
CA3031797A1 (en) 2016-08-05 2018-02-08 Sanofi Pasteur, Inc. Multivalent pneumococcal polysaccharide-protein conjugate composition
SG11201900794PA (en) * 2016-08-05 2019-02-27 Sanofi Pasteur Inc Multivalent pneumococcal polysaccharide-protein conjugate composition
MX2019002552A (es) 2016-09-06 2019-07-01 Lg Chemical Ltd Composicion que comprende polisacarido capsular neumococico multivalente-proteina transportadora y uso de la misma.
JP2019529497A (ja) * 2016-09-30 2019-10-17 バイオロジカル イー リミテッド 多糖類−タンパク質コンジュゲートを含む多価肺炎球菌ワクチン組成物
KR20200051005A (ko) 2017-09-07 2020-05-12 머크 샤프 앤드 돔 코포레이션 폐렴구균 폴리사카라이드 및 면역원성 폴리사카라이드-담체 단백질 접합체에서의 그의 용도
AU2018328037B2 (en) 2017-09-07 2024-03-07 Merck Sharp & Dohme Llc Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates
CA3074714A1 (en) 2017-09-07 2019-03-14 Merck Sharp & Dohme Corp. Processes for the formulation of pneumococcal polysaccharides for conjugation to a carrier protein
MX2020002557A (es) 2017-09-07 2020-07-13 Merck Sharp & Dohme Polisacaridos neumococicos y su uso en conjugados de polisacarido inmunogenico con proteina.
US20200330579A1 (en) 2017-10-04 2020-10-22 Liffey Biotech Limited Saccharide-polypeptide conjugate compositions and methods of use thereof
SG11202005255PA (en) 2017-12-06 2020-07-29 Merck Sharp & Dohme Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof
AU2019215212A1 (en) 2018-02-05 2020-07-23 Sk Bioscience Co., Ltd. Multivalent pneumococcal polysaccharide-protein conjugate composition
AU2019215216A1 (en) * 2018-02-05 2020-07-23 Sk Bioscience Co., Ltd. Multivalent pneumococcal polysaccharide-protein conjugate composition
US11951162B2 (en) 2018-04-18 2024-04-09 Sk Bioscience Co., Ltd. Streptococcus pneumoniae capsular polysaccharides and immunogenic conjugate thereof
CA3148824A1 (en) 2019-07-31 2021-02-04 Sanofi Pasteur Inc. Multivalent pneumococcal polysaccharide-protein conjugate compositions and methods of using the same

Also Published As

Publication number Publication date
PH12020551149A1 (en) 2021-05-31
JP2022068303A (ja) 2022-05-09
US20210077608A1 (en) 2021-03-18
WO2019152925A1 (en) 2019-08-08
JP7318034B2 (ja) 2023-07-31
JP2023134727A (ja) 2023-09-27
JP7030235B2 (ja) 2022-03-04
AR127517A2 (es) 2024-01-31
TWI826420B (zh) 2023-12-21
US11123417B2 (en) 2021-09-21
IL276230B1 (en) 2023-09-01
CN111757753A (zh) 2020-10-09
CA3089007A1 (en) 2019-08-08
KR20230008923A (ko) 2023-01-16
IL276230A (en) 2020-09-30
JP6950099B2 (ja) 2021-10-13
KR102486891B1 (ko) 2023-01-10
EP3749357A4 (en) 2022-04-20
KR20200120926A (ko) 2020-10-22
JP2022000449A (ja) 2022-01-04
AU2019215216A1 (en) 2020-07-23
BR112020015696A2 (pt) 2020-12-08
IL276230B2 (en) 2024-01-01
US20210401963A1 (en) 2021-12-30
EP3749357A1 (en) 2020-12-16
WO2019152925A8 (en) 2020-07-16
JP2021511367A (ja) 2021-05-06
IL304977A (en) 2023-10-01
US11911452B2 (en) 2024-02-27
ZA202202600B (en) 2023-10-25
SG11202006388SA (en) 2020-07-29
TW201934140A (zh) 2019-09-01

Similar Documents

Publication Publication Date Title
MX2020008198A (es) Composicion del conjugado proteina-polisacarido multivalente neumococica.
PH12020551147A1 (en) Multivalent pneumococcal polysaccharide-protein conjugate composition
SA519401027B1 (ar) تركيب متقارن من عديد السكاريد للمكورة الرئوية متعددة التكافؤ - وبروتين
SA519401028B1 (ar) تركيب متقارن من عديد السكاريد للمكورة الرئوية متعددة التكافؤ - وبروتين
MX2022001241A (es) Composiciones de conjugados neumococicos multivalentes polisacarido - proteina y metodos para usar los mismos.
NZ765694A (en) Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof
MX358148B (es) Composicion de conjugados de proteina-polisacaridos multivalentes para neumococos.
NZ601711A (en) 15-valent pneumococcal polysaccharide-protein conjugate vaccine composition
PH12015501269B1 (en) Multivalent pneumococcal polysaccharide-protein conjugate composition
JP2019526621A5 (es)
MX2009006705A (es) Composicion conjugada polisacarido-proteina neumococica multivalente.
MX2009006547A (es) Composicion conjugada polisacarido-proteina neumococica multivalente.
MX2009006548A (es) Composicion conjugada polisacarido-proteina neumococica multivalente.
MX2013006539A (es) Formulaciones novedosas que mitigan la agregacion inducida por agitacion de composiciones inmunogenicas.
MY150719A (en) Pneumococcal polysaccharide conjugate vaccine
MX2009013949A (es) Vacuna que comprende conjugados de polisacárido capsular de streptococcus pneumoniae.
JP2019526620A5 (es)
MX2017016828A (es) Vacuna conjugada neumococica polivalente.
EA202091439A1 (ru) Поливалентная противопневмококковая полисахаридно-белковая конъюгированная композиция
AR114355A1 (es) Composición del conjugado proteína-polisacárido multivalente neumocócica
AR114442A1 (es) Composición del conjugado proteína-polisacárido multivalente neumocócica
EA201990131A1 (ru) Поливалентная пневмококковая полисахаридно-белковая конъюгатная композиция
AR122291A1 (es) Composiciones conjugadas neumocócicas multivalentes polisacárido - proteína y métodos para usar las mismas
AR109377A1 (es) Composición conjugada neumocócica multivalente de polisacárido y proteína